Navigation Links
'Hot spot' for toxic harmful algal blooms discovered off Washington coast
Date:1/30/2009

A part of the Strait of Juan de Fuca, which separates Washington state from Canada's British Columbia, is a potential "hot spot" for toxic harmful algal blooms affecting the Washington and British Columbia coasts.

Marine scientists found that under certain conditions, toxic algal cells from an offshore "initiation site" break off and are transported to nearshore areas, where they may trigger harmful algal blooms that ultimately force the closure of Washington state shellfish beds along beaches.

"Knowing more about these blooms is critical for protecting human and ecosystem health," said David Garrison, director of the National Science Foundation (NSF)'s Biological Oceanography Program, which co-funded the research. "This research is a very successful step toward addressing harmful algal blooms in the U.S."

The study, conducted by a team of scientists from NOAA's Fisheries Service, San Francisco State University and the universities of Washington, Maine and Western Ontario, is part of the interagency Ecology and Oceanography of Harmful Algal Blooms Pacific Northwest Program.

"Understanding how and where harmful algal blooms originate will help provide early warnings to protect human health and reduce the impact of biotoxins on coastal shellfisheries," said Vera Trainer, lead author of a paper published in the January issue of the journal Limnology & Oceanography, and a scientist at the NOAA Fisheries Northwest Fisheries Science Center in Seattle.

Scientists noted that the Juan de Fuca eddy, a circular water mass rotating some 30 miles off the northern coast of Washington at the mouth of the Juan de Fuca Strait, frequently contained significant populations of the microscopic toxic alga, Pseudo-nitzschia.

Over the course of the five-year study, the researchers took thousands of measurements at sea and conducted experiments onboard research vessels and in their laboratories. They hoped to better underst
'/>"/>

Contact: Cheryl Dybas
cdybas@nsf.gov
703-292-7734
National Science Foundation
Source:Eurekalert

Page: 1 2

Related biology news :

1. Researchers identify 4 genetic hotspots associated with psoriasis
2. BIO-key(R) Fingerprint Biometrics Media Spotlights
3. Molecules in the spotlight
4. New model predicts hot spots for mercury in fish
5. Jupiters shrinking red spot
6. Neuroinformatics special issue spotlights the Neuroscience Information Framework
7. Spotlight on cosmetic ingredients conference
8. Farmers can spot lame sheep, but fail to prevent footrot spread
9. New method identifies meth hot spots
10. Major European program for the environment under the spotlight in Lille, France
11. Fossil and molecular evidence reveals the history of major marine biodiversity hotspots
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/11/2015)... , May 11, 2015 Curemark LLC, a ... start of a new Phase III double blind, randomized, ... novel formulation, CM-AT, on all children ages 3-8 with ... FDA Phase III double blinded clinical trial for CM-AT ... levels of the digestive enzyme chymotrypsin. This new trial ...
(Date:5/5/2015)... Conn. , May 5, 2015, NXT-ID, Inc. ... authentication company focused on the growing mobile commerce market, reminds ... Company,s Chief Technology Officer, is presenting  at CARTES SECURE CONNEXIONS ... May 5-7, 2015. The three-day conference is ... David is speaking in is themed Global Fraud: Where ...
(Date:4/20/2015)... PASADENA, Calif. , April 20, 2015 ... San Gabriel Valley to implant a new miniaturized, wireless ... HF System is the first and only FDA-approved heart ... reduce hospital admissions when used by physicians to manage ... a sensor that is implanted in the pulmonary artery ...
Breaking Biology News(10 mins):Curemark, LLC, Launches New Phase III Trial in Expanded Population of Children with Autism 2NXT-ID, Inc.'s CTO, David Tunnell, Presents at CARTES SECURE CONNEXIONS AMERICA 2015 Today in Washington DC. 2NXT-ID, Inc.'s CTO, David Tunnell, Presents at CARTES SECURE CONNEXIONS AMERICA 2015 Today in Washington DC. 3Huntington Memorial Hospital Becomes First in the San Gabriel Valley to Offer Patients a New Heart Failure Monitoring Solution 2Huntington Memorial Hospital Becomes First in the San Gabriel Valley to Offer Patients a New Heart Failure Monitoring Solution 3
... for a "Fontaine de Jouvence" forever; a way to ... found, we are making,progress; in worms. Researchers found that ... of prolonging the life span of C.,Elegans: ,A class ... according to researchers at Washington University School of,Medicine in ...
... a,potential target for a drug seems very promising on ... case of telomerase inhibitors,to treat cancer; they are supposed ... cancer cells. Yet, something in the cell,seems to block ... to do then? Scrap the project? Look for something,else? ...
... to DNA and identifying the genes they regulate just ... by scientists at the U.S.,Department of Energy’s Brookhaven National ... the role these proteins,play in turning on and off ... they brain cells, liver, or blood ?as well as ...
Cached Biology News:Research on Worms Yields Clues on Aging 2Combination therapy boosts effectiveness of telomere-directed cancer cell death 2New Technique for Tracking Gene Regulators 2New Technique for Tracking Gene Regulators 3
(Date:5/21/2015)... St. Louis, MO (PRWEB) May 21, 2015 ... that assesses the safety and efficacy of pharmaceutical products ... Access Drive Maryland Heights, MO 63043, a 50,000 sq. ... their current location, to enable strategic growth. Facility renovations ... offices to the new space will occur in September. ...
(Date:5/21/2015)... 2015 uBiome, the leading startup ... with PicnicHealth, a healthcare company that collects and ... Inflammatory Bowel Disease (IBD) will receive a complementary ... research kit. Both companies were funded by Y ... For more information on this partnership and how ...
(Date:5/21/2015)... 21, 2015 Patent Offering, The patent’s ... diagnostic or therapeutic imaging within a body lumen (open ... endoscope having a low cost, single-use disposable illumination and ... was October 18, 2013 and the patent approval was ... the physician to customize the lighting and magnification of ...
(Date:5/21/2015)... - RepliCel Life Sciences Inc. (TSX.V: RP) (OTCQB: ... on the development of autologous cell therapies, announced ... Society for Cellular Therapy (ISCT) on RepliCel,s autologous ... a Phase 1/2 clinical trial.  The presentation, taking ... PM to 7:00 PM local time, will review ...
Breaking Biology Technology:Seventh Wave Laboratories Purchases Building for Expansion, Upcoming Move 2Seventh Wave Laboratories Purchases Building for Expansion, Upcoming Move 3uBiome Partners with PicnicHealth 2uBiome Partners with PicnicHealth 3IpAuctions™ Presents The Worlds Smallest Disposable Illuminated Endoscope For Auction 2IpAuctions™ Presents The Worlds Smallest Disposable Illuminated Endoscope For Auction 3RepliCel to Present Unique Autologous Cell Treatment for Achilles Tendinosis at International Society for Cellular Therapy Conference 2RepliCel to Present Unique Autologous Cell Treatment for Achilles Tendinosis at International Society for Cellular Therapy Conference 3
...  Intimate Bridge 2 Conception, Inc. (Ib2C™), a Pittsburgh-based direct-to-consumer ... announced today that it has closed on a $4.3 ... a private, Pennsylvania-based investment group and was joined by ... of this round for manufacturing and marketing to prepare ...
... coat of paint you put on the outside of your ... power the appliances and equipment on the inside. A ... made a major advance toward this vision by creating an ... "We want to do something transformative, to move beyond ...
... recently licensed from Yale University a new clinical diagnostic ... treating patients with melanoma to identify a subset of ... their lymph nodes, have a 40% risk of recurrence ... IHC testing method that enables measurement of protein biomarkers ...
Cached Biology Technology:Intimate Bridge 2 Conception, Inc. Receives $4.3M 2Intimate Bridge 2 Conception, Inc. Receives $4.3M 3Notre Dame researchers develop paint-on solar cells 2HistoRx Licenses Melanoma Assay from Yale University 2
Mycoplasma Removal Agent (MRA) has been developed for cell culture, to combat the widespread problems caused by contamination of cell cultures with mycoplasma....
albumin from bovine serum (BSA), 2,4-dinitrophenylated (DNP-BSA)...
Request Info...
albumin from bovine serum (BSA), Alexa Fluor® 647 conjugate...
Biology Products: